Current Thoracic Surgery

Lung cancer is one of the leading cause of mortality around the world, and it is widely known that survival is limited in metastatic lung carcinoma cases. However, in oligometastatic, non-small cell lung carcinoma cases, surgical excision of both the primary tumor and the metastatic site may yield a survival advantage in selected cases. In non-small cell lung carcinoma cases, especially after metastasectomy of brain and adrenal gland metastasis, studies in which survival advantage is reported are common in the literature, and metastasectomy is the treatment method applied to selected patient groups in brain and adrenal gland metastases. In surgical treatment of extra-cranial and extra-adrenal oligometastasis, on the other hand, there are several cases in which morbidity-free survival rates were reported after successful management. In this report, the surgical treatment results were evaluated, and the contribution of treatment methods to survival rates were investigated in extrapulmonary oligometastatic non-small cell lung carcinoma cases receiving surgical excision.